Solara Active Pharma Science has informed that the Company has entered into a Business transfer agreement with SeQuent Scientific Limited for sale of API facility at Mahad, India. The total consideration for the unit would be Rs 464 Mn.
The above information is a part of company’s filings submitted to BSE.